Novartis immunologist describes the excitement of discovering a promising new immuno-oncology (IO) target in the treatment of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).

New Global Head of Cardiovascular and Metabolic Diseases Research looks to apply new tools to address tough challenges.

A complex protein module keeps the liver’s biochemical factory running smoothly and at capacity.

Investing in innovative treatments is vital to alleviate the suffering caused by multiple sclerosis (MS).

Jordan, a melanoma survivor, shares her experience with melanoma, BRAF mutation testing and the importance of patient empowerment.

Improved versions of our new digital platform for heart failure disease management in China have been developed since April, 2020 rollout.

To understand the impact of psoriasis on those who live with it, we helped organize a global survey of more than 8,000 people who have this skin condition. Then we commissioned a body painter to bring the results to life, using skin as her canvas.

Melanoma survivor T.J. Sharpe shares why patients should know their treatment options.

Ron Hollander, president of the International Neuroendocrine Cancer Alliance, talks to us about patient advocacy.